Description:
Home Page: www.bioinvent.com
The Gamma Building
Lund,
223 70
Sweden
Phone:
46 4 62 86 85 50
Officers
| Name | Title |
|---|---|
| Dr. Martin Welschof Ph.D. | Pres & CEO |
| Mr. Stefan Ericsson M.B.A. | Chief Financial Officer |
| Ms. Marie Moores M.Sc., R.G.N. | Chief Operating Officer |
| Mr. Kristoffer Rudenholm Hansson | Sr. VP of Technical Operations |
| Mr. Björn Frendéus | Chief Scientific Officer |
| Ms. Cecilia Hofvander | Sr. Director of Investor Relations |
| Dr. Andres McAllister | Chief Medical Officer |
| Ms. Ingrid Teige | Head of Preclinical Research |
| Ms. Sylvie Ryckebusch | Chief Bus. Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.3224 |
| Price-to-Sales TTM: | 11.5338 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 102 |